Moderna: Moderna, Inc.: Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
CAMBRIDGE, MA / ACCESS Newswire / April 10, 2025 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 1, 2025 to repo...
Read full article »
Moderna is a Massachusetts-based biotechnology company that researches and develops mRNA therapeutics for the treatment of cardiovascular and autoimmune diseases.
Read more